Obermatt
See Similar Stocks →

Cegedim

PAR:ALCGM · FR0000053506
Health Care TechnologySmall

360

65
EV / EBIT75
Price / Owner Earnings15
Owner Earnings Yield61
Dividend Yield1
Price/Sales95
EV / Gross Profit80
Price/Book84
Return on Capital61
Cash Return on Capital59
Return on Equity57
EBIT Margin53
Gross Profitability47
Cash Conversion93
Accruals58
Owner Earnings Margin57
Sales growth24
Profit Growth44
Long-Term EPS Growth28
Reinvestment46
Price momentum50
Debt load14
Refinancing1
Debt Payback12
Liquidity38
Analyst ratings7
Opinion Changes4
Price Target Upside54
Market mood35
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Cegedim clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryFrance
IndustryHealth Care Technology
SizeSmall
TypePublic Company
ExchangeENXTPA
Founded1969
Employees1,125
Websitecegedim.fr
ISINFR0000053506
Last UpdateApr 2, 2026
Index & Theme
Artificial IntelligenceCloud InfrastructureMachine LearningProcess AutomationCloud Data ServicesEDI (Electronic Data Interchange)Software DevelopmentCRMHealth CareInformation Technology

Description

Cegedim SA is an innovative technology and services group, focusing on digital data flow management for healthcare ecosystems and B2B applications. Additionally, it operates as a business software publisher catering to healthcare and insurance profes…

Analysis

Middle-of-the-road

Cegedim SA sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 25.8×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is stretched. The company scores 8/20 on our value-creation score: creating some value.

Flags to be aware of: The financial cushion is thinner than comfortable. Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
9
2023202420252026

All-time high

38

Jan 2024

All-time low

1

Mar 2026

Average rank

17

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
95
87
85
87
Price/Earnings
66
97
90
88
Price/Book
84
86
86
84
Dividend Yield
1
1
54
1
Value (overall)
75
77
89
75

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Cegedim with its peers
Fagron
BRU:FAGR
86
CountryBelgium
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Sectra
STO:SECT B
65
CountrySweden
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
Equasens
PAR:EQS
40
CountryFrance
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
Haleon
LSE:HLN
31
CountryUK
IndustryPharmaceuticals
SizeX-Large
Full Stock Analysis →
Unilever
LSE:ULVR
43
CountryUK
IndustryPersonal Products
SizeXX-Large
Full Stock Analysis →
Transgene
PAR:TNG
15
CountryFrance
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →